Dillon O. Flynn

Incidence, Patterns and Predictors of Alemtuzumab‐Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study

ABSTRACT Background Alemtuzumab (Lemtrada) is highly effective for selected relapsing multiple sclerosis (MS) but can cause autoimmune thyroid dysfunction (AITD). Our aim was to retrospectively review patients and the monitoring of their thyroid function tests (TFTs) during and a...